Please join me in supporting The Leukemia & Lymphoma Society (LLS) by making a donation to our fundraising campaign. Your contributions will help fund life saving blood cancer research, drug therapies and treatment.
RageOn has pioneered the art of made-to-order dye-sublimation, also known as all-over-printing, which enables print and design of any colors across the entirety of a product; essentially limitless! By printing on a made-to-order basis, RageOn saves money on inventory and storage, and is 100% green with zero waste.
I will be pitching this idea to a panel of notable VC's and entrepreneurs on Sat, Oct 21. Join me for the pitch competition dinner and benefit gala at the Fairmont Hotel. Your donations are tax deductible and 100% of the net proceeds go to LLS. Learn more.
Pitch Competition (October 21, 6:30 pm)
During an elegant dinner, watch some of San Francisco's sharpest innovators pitch their ideas to a panel of judges comprised of notable Venture Capitalists, Entrepreneurs, and an audience of potential investors. The winner of the competition will be announced onstage at Midnight, during the black-tie benefit gala. Purchase Dinner/Gala tickets.
Benefit Gala (October 21, 9:30 pm)
Immediately following dinner, the stylish black-tie gala takes place. The Mr|Ms Silicon Valley Benefit Gala features world class DJ's & performers, live entertainment, and over 800 of San Francisco's finest young professionals celebrating good times for a great cause. The winner of the Pitch Competition will be announced live on stage at Midnight. Purchase Gala tickets.
Meet the Hosts
HackCancer is a group of philanthropic, young professionals in the San Francisco Bay Area. We host fun, engaging events that bring great people together to raise awareness and funding for cancer-related charities.
The Leukemia & Lymphoma Society's mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma while improving the quality of life for patients and their families. LLS invests in cures because most blood cancers cannot be prevented or detected early. Their continued advancements are now being used to treat patients with rare forms of stomach and skin cancers. In addition, their therapies are also being tested in clinical trials for patients with lung, brain, breast, pancreatic and prostate cancers. Research funded by LLS has tripled and in some cases quadrupled patient survival rates.
On behalf of HackCancer, LLS and blood cancer patients everywhere we thank you for your support!